Medicare will increase payment for certain "high-throughput" COVID-19 diagnostic tests to $100 to expand testing capacity and speed results during the public health emergency, the Centers for Medicare & Medicaid Services announced yesterday. The tests can process more than 200 specimens a day but require specially trained technicians and more time-intensive processes to assure quality. CMS expects the payment increase to allow laboratories to expand testing, particularly to vulnerable nursing home patients. Medicare administrative contractors previously paid about $51 for these clinical laboratory diagnostic tests under Medicare Part B.

Related News Articles

Headline
The Food and Drug Administration yesterday released COVID-19 performance data for four more antibody test kits. The results come from the first collaboration…
Headline
The Department of Health and Human Services today released guidance specifying what data laboratories must report to HHS along with their COVID-19 test results…
Headline
The Food and Drug Administration this week released guidance for institutional review boards seeking clarity regarding the key factors and procedures they…
Headline
Social distancing interventions started earlier in the COVID-19 epidemic appear to delay the epidemic curve while interventions started later appear to flatten…
Headline
The Centers for Medicare & Medicaid Services recently issued new guidance implementing the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group,…
Headline
The Senate yesterday approved by unanimous consent the AHA-supported Paycheck Protection Program Flexibility Act of 2020 (H.R. 7010) to allow more leeway for…